01530.HK
3SBio Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 15.75
−1.44%Next report
Analyst consensus
- Next report date
- Mar 30, 2027
- EPS estimate
- HKD 0.57
- Revenue estimate
- HKD 5.4B
Latest reported
- Last report date
- Aug 20, 2026
- EPS actual
- HKD 0.51
- EPS estimate
- HKD 0.74
- Revenue actual
- HKD 5.2B
- Revenue estimate
- HKD 5.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -31.3%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 20, 2026 | HKD 0.74 | HKD 0.51 | Miss -31.26% | HKD 5.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027